Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Trypanosoma Cruzi (T. cruzi)
49%
Mycobacterium Tuberculosis (M. tb)
40%
Chagas Disease
37%
Guided Synthesis
37%
Xenobiotics
37%
Drug Metabolism
37%
Infectious Diseases
37%
Drug Development
37%
Drug Discovery
37%
Pyridazinone
37%
Suramin
37%
Structure-based Design
37%
African Trypanosomes
37%
Protease Inhibitors
37%
Humanized Models
37%
Spike Glycoprotein
37%
Emerging Human Pathogen
37%
Mycobacterium Abscessus
37%
Mycobacterium Avium
37%
Dihydrofolate Reductase Inhibitors
37%
Substituted piperazine
37%
2,4-diaminopyrimidine
37%
ISG75
31%
Methylenetetrahydrofolate Reductase (MTHFR)
28%
Wild Mice
25%
Metabolism
24%
Drug Interactions
18%
Compound 8
18%
Preclinical Safety Study
18%
Mouse Infection
12%
Metabolic
12%
Clinical Translation
12%
Absorption Distribution
12%
Leishmania
12%
Central America
12%
Parasitic Infection
12%
Gene Superfamily
12%
Visceral Leishmaniasis
12%
Clinically Significant
12%
Leishmania Donovani
12%
Disease Areas
12%
Cryogenic Electron Microscopy
12%
Metabolite Profile
12%
South America
12%
Trypanosoma
12%
Co-structure
12%
Pharmacokinetics
12%
Compound Attrition
12%
Drive Optimization
12%
Well Tolerated
12%
Immunology and Microbiology
Infectious Disease
100%
Infection
100%
Drug Metabolism
74%
Mouse Model
71%
Trypanosoma Cruzi
56%
Wild Type Mouse
49%
Species Difference
43%
Transfer RNA
37%
Xenobiotic
37%
Plasmodium berghei
37%
Glycoprotein
37%
Antimalarial Agent
37%
Cryptosporidium
37%
Trypanosoma
37%
Metabolite
37%
Proteasome
37%
Cytochrome P450
31%
Pharmacokinetics
26%
Chagas Disease
22%
In Vitro
19%
Mycobacterium Tuberculosis
18%
Drug-Drug Interaction
18%
Leishmania donovani
18%
Parasite
14%
Protozoa
12%
Antigenic Variation
12%
Erythrocyte
12%
Trypanosomatid
12%
Plasmodium falciparum
12%
Drug Efficacy
12%
CRISPR/Cas9
12%
Engraftment
12%
Drug Interaction
12%
Plasmodium
12%
Innate Immune System
12%
Immune Evasion
12%
Null Cell
12%
B Cell
12%
T Cell
12%
Natural Killer Cell
12%
Malaria
12%
Parasitic Disease
7%
Visceral Leishmaniasis
7%
Leishmania
7%
Cryo-Electron Microscopy
7%
Absorption
7%
Pharmacology, Toxicology and Pharmaceutical Science
Chagas Disease
74%
Infection
74%
Trypanosoma Cruzi
68%
Diseases
43%
Pharmacokinetics
40%
Piperazine Derivative
37%
Proteasome Inhibitor
37%
Drug Discovery
37%
Proteasome
37%
Lysine Transfer RNA Ligase
37%
Drug Development
37%
Drug Metabolism
37%
Cryptosporidium
37%
Mycobacterium avium
37%
Mycobacterium abscessus
37%
Dihydrofolate Reductase Inhibitor
37%
Parasite
37%
Mouse Model
31%
Dihydrofolate Reductase
28%
Atypical Mycobacterium
28%
Wild Type Mouse
25%
Piperazine
18%
Parasitosis
12%
Visceral Leishmaniasis
12%
Drug-Drug Interaction
12%
Leishmania
12%
Efficacy Study
12%
Efficacy Assessment
12%
Mycobacterium Tuberculosis
12%
Leishmania donovani
12%
Cryo-Electron Microscopy
12%
Cytochrome P450
12%
Active Metabolite
12%
Gastrointestinal Infection
9%
Cryptosporidiosis
9%
Nitazoxanide
9%
Cell Culture
9%
Gram Negative Infection
9%
Lung Disease
9%
Antibiotics
9%
Gram Negative Bacterium
9%
Atypical Mycobacteriosis
9%
Enzymes
9%